Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

August 2013 - FRMC

Linaclotide and Sexual Subscale Scores on IBS-QOL
08/15/2013

Tori Socha

Tori Socha
Irritable bowel syndrome (chronic functional gastrointestinal disorder) causes low quality of life and psychosocial wellbeing, and decreased sexual desire.
Irritable bowel syndrome (chronic functional gastrointestinal disorder) causes low quality of life and psychosocial wellbeing, and decreased sexual desire.
Irritable bowel...
08/15/2013
First Report Managed Care
Patient-Reported Outcomes in Assessing IBS Severity
08/15/2013

Tori Socha

Tori Socha
  Orlando—Characterizing the therapeutic benefit of novel agents for irritable bowel syndrome relies heavily on patient-reported outcomes (PROs) assessing multiple gastrointestinal symptoms. Common approaches that sum or average responses...
  Orlando—Characterizing the therapeutic benefit of novel agents for irritable bowel syndrome relies heavily on patient-reported outcomes (PROs) assessing multiple gastrointestinal symptoms. Common approaches that sum or average responses...
  Orlando—Characterizing the...
08/15/2013
First Report Managed Care
Patient-Physician Interactions: Patients with IBS
08/15/2013

Tori Socha

Tori Socha
Previous studies have demonstrated that an effective patient-physician relationship can improve clinical outcomes in patients with irritable bowel syndrome (IBS).
Previous studies have demonstrated that an effective patient-physician relationship can improve clinical outcomes in patients with irritable bowel syndrome (IBS).
Previous studies have...
08/15/2013
First Report Managed Care
Phentermine and Topiramate for Patients with Dysglycemia
08/15/2013

Tim Casey

Tim Casey
Chicago—Obese or overweight adults with dysglycemia who received phentermine and topiramate extended-release pills had a mean weight loss of 7.7% to 11.6% after 56 weeks of treatment, according to a post hoc analysis of a randomized,...
Chicago—Obese or overweight adults with dysglycemia who received phentermine and topiramate extended-release pills had a mean weight loss of 7.7% to 11.6% after 56 weeks of treatment, according to a post hoc analysis of a randomized,...
Chicago—Obese or overweight...
08/15/2013
First Report Managed Care
Linagliptin and Cardiovascular Risk
08/15/2013

Tim Casey

Tim Casey
Chicago—Patients with type 2 diabetes who took linagliptin were not at higher risk of having cardiovascular events compared with patients who took other drugs, according to an analysis of 19 multicenter, randomized, double-blind, parallel...
Chicago—Patients with type 2 diabetes who took linagliptin were not at higher risk of having cardiovascular events compared with patients who took other drugs, according to an analysis of 19 multicenter, randomized, double-blind, parallel...
Chicago—Patients with type 2...
08/15/2013
First Report Managed Care
Pooled Data Analysis of Canagliflozin
08/15/2013

Tim Casey

Tim Casey
Chicago—Compared with a group receiving placebo, patients with type 2 diabetes who took 100 mg or 300 mg of canagliflozin had improvements in glycemic control and reductions in body weight, according to a pooled data analysis of 4 randomized,...
Chicago—Compared with a group receiving placebo, patients with type 2 diabetes who took 100 mg or 300 mg of canagliflozin had improvements in glycemic control and reductions in body weight, according to a pooled data analysis of 4 randomized,...
Chicago—Compared with a group...
08/15/2013
First Report Managed Care
Investigational Agent Dulaglutide versus Exenatide and Placebo
08/15/2013

Tim Casey

Tim Casey
Chicago—After 26 weeks of treatment, patients with type 2 diabetes who received dulaglutide once weekly had a statistically significant reduction in hemoglobin A1c (HbA1c) levels compared with a placebo group and patients who took exenatide,...
Chicago—After 26 weeks of treatment, patients with type 2 diabetes who received dulaglutide once weekly had a statistically significant reduction in hemoglobin A1c (HbA1c) levels compared with a placebo group and patients who took exenatide,...
Chicago—After 26 weeks of...
08/15/2013
First Report Managed Care
Combination of Liraglutide and Insulin Degludec
08/15/2013

Tim Casey

Tim Casey
Chicago—According to a randomized, open-label, phase 3 trial, patients with type 2 diabetes who received a combination of liraglutide and insulin degludec had significant reductions in hemoglobin A1c (HbA1c) levels after 26 weeks compared...
Chicago—According to a randomized, open-label, phase 3 trial, patients with type 2 diabetes who received a combination of liraglutide and insulin degludec had significant reductions in hemoglobin A1c (HbA1c) levels after 26 weeks compared...
Chicago—According to a...
08/15/2013
First Report Managed Care

Department

Conference Insider
Trends in Ambulatory Care for IBS, 1993-2010
08/15/2013

Tori Socha

Tori Socha
Researchers conducted a study to identify trends in IBS-related physician visits, evaluation, and management in the United States over the past 2 decades.
Researchers conducted a study to identify trends in IBS-related physician visits, evaluation, and management in the United States over the past 2 decades.
Researchers conducted a study to...
08/15/2013
First Report Managed Care
Conference Insider
Analysis of a Veterans Affairs Lifestyle Change Program
08/15/2013

Tim Casey

Tim Casey
Chicago—An analysis of a large lifestyle change program in patients with type 2 diabetes found that diet and exercise modification can help patients, although <10% of participants were actively involved in the program. Sandra L. Jackson,...
Chicago—An analysis of a large lifestyle change program in patients with type 2 diabetes found that diet and exercise modification can help patients, although <10% of participants were actively involved in the program. Sandra L. Jackson,...
Chicago—An analysis of a large...
08/15/2013
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 2

Current Issue

June 2024
Volume 21
Issue 2
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

Conference Insider
Managing Chronic Kidney Disease in Older Adults
11/03/2014

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
Chronic kidney disease is pervasive in the older population. The progression of CKD can have a significant affect on the overall prognosis of a geriatric patient.
Chronic kidney disease is pervasive in the older population. The progression of CKD can have a significant affect on the overall prognosis of a geriatric patient.
Chronic kidney disease is...
11/03/2014
First Report Managed Care
News
Retirement, health insurance commonly targeted
08/04/2011
08/04/2011
First Report Managed Care
News
US Government Proposes More Transparency in Clinical Trials
11/19/2014
Health officials proposed significantly expanding what researchers are required to report about clinical trials of drugs, devices, and other interventions.
Health officials proposed significantly expanding what researchers are required to report about clinical trials of drugs, devices, and other interventions.
Health officials proposed...
11/19/2014
First Report Managed Care
News
Device Could Reduce Direct Medical Costs For Patients with COPD
11/15/2017
Recent research in the International Journal of COPD found that a handheld mechanical oscillating positive expiratory pressure device could significantly improve post-exacerbation care.
Recent research in the International Journal of COPD found that a handheld mechanical oscillating positive expiratory pressure device could significantly improve post-exacerbation care.
Recent research in...
11/15/2017
First Report Managed Care
News
Pelosi: Public option will not be in health bill despite liberal efforts
03/12/2010
03/12/2010
First Report Managed Care

Video Insights

Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care
Joe DePinto Headshot
Videos
Navigating Payment Models in the CGT Landscape: Insights and Innovations
05/21/2024
Joe DePinto, Head of Cell, Gene, and Advanced Therapies, McKesson
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the...
05/21/2024
First Report Managed Care
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP
Videos
Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations
05/15/2024
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in...
05/15/2024
First Report Managed Care
Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, head o...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health
03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of...
03/27/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care
Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consultant ...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Mansur Shomali
Videos
Advancements and Challenges in Diabetes Management
02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health 

Featuring Mansur Shomali, MD, chief m...
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital...
02/27/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

August 2013 Volume 10 Issue 8

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement